Publications

Seasonality of acute kidney injury phenotypes in England: an unsupervised machine learning classification study of electronic health records.

BOLT, H; SUFFEL, A; MATTHEWMAN, J; Sandmann, F; TOMLINSON, L; EGGO, R;

2023

BMC nephrology, (2023).24 1 10.1186/s12882-023-03269-0.

Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models.

Giddings, R; INDRAVUDH, P; MEDLEY, GF; BOZZANI, F; GAFOS, M; Malhotra, S; TERRIS-PRESTHOLT, F; TORRES-RUEDA, S; Quaife, M;

2023

PharmacoEconomics, (2023).41 6 10.1007/s40273-023-01260-z.

Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England.

Clifford, S; Waight, P; Hackman, J; Hué, S; Gower, C; Kirsebom, FC M; Skarnes, C; Letley, L; Lopez Bernal, J; Andrews, N; FLASCHE, S; MILLER, E;

2023

Wellcome Open Res (2023). 10.12688/wellcomeopenres.17995.2.

Quantifying the relationship between climatic indicators and leptospirosis incidence in Fiji: A modelling study.

Rees, EM; Lotto Batista, M; Kama, M; KUCHARSKI, AJ; Lau, CL; LOWE, R;

2023

PLOS global public health, (2023).3 10 10.1371/journal.pgph.0002400.

Improving modelling for epidemic responses: reflections from members of the UK infectious disease modelling community on their experiences during the COVID-19 pandemic.

SHERRATT, K; Carnegie, A; Kucharski, A; Cori, A; Pearson, C; Jarvis, C; Overton, C; Weston, D; Hill, E; Knock, E; Fearon, E; NIGHTINGALE, E; Hellewell, J; Edmunds, J; Arenas, JV; Prem, K; Pi, L; Baguelin, M; Kendall, M; Ferguson, N; DAVIES, N; Eggo, R; Van Elsland, S; RUSSELL, T; FUNK, S; ... Abbott, S.

2023

bioRxiv (2023). 10.1101/2023.06.12.544667.

Dengue virus type I isolate DEN-P-1098-1 polyprotein (POLY) gene, partial cds.

Ashall, J; SHAH, S; Biggs, JR; Chang, J-NR; Jafari, Y; Brady, OJ; Mai, HK; Lien, LT; Do Thai, H; Nguyen, HA T; Anh, DD; Iwasaki, C; Kitamura, N; Van Loock, M; Herrera-Taracena, G; Rasschaert, F; Van Wesenbeeck, L; Yoshida, L-M; HAFALLA, JC R; HUE, S; HIBBERD, ML;

2023

, National Center for Biotechnology Information (2023).

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.

Achar, J; Seddon, JA; KNIGHT, GM; Dodd, PJ; Esmail, H; Hughes, J; MCQUAID, CF;

2023

The European Respiratory Journal, (2023).62 5 10.1183/13993003.00969-2023.

Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines.

WATERLOW, NR; PROCTER, SR; EGGO, RM; JIT, M;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02996-3.

Impact of vaccinations, boosters and lockdowns on COVID-19 waves in French Polynesia.

Chapman, LA C; Aubry, M; Maset, N; RUSSELL, T; Knock, E; Lees, J; Mallet, H-P; Cao-Lormeau, V-M; KUCHARSKI, A;

2023

medRxiv (2023). 10.1101/2023.03.29.23287906.

Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.

ZHENG, B; TAZARE, J; Nab, L; Green, AC; Curtis, HJ; MAHALINGASIVAM, V; HERRETT, EL; COSTELLO, RE; EGGO, RM; Speed, V; Bacon, SC; Bates, C; Parry, J; Cockburn, J; Hester, F; Harper, S; Schaffer, AL; Hulme, WJ; Mehrkar, A; EVANS, SJ; MacKenna, B; GOLDACRE, B; DOUGLAS, IJ; TOMLINSON, LA; OpenSAFELY Collaborative,;

2023

The Lancet Regional Health - Europe, (2023).34, 10.1016/j.lanepe.2023.100741.